Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 118   

Articles published

JNJ 107.88 -0.11 (-0.10%)
price chart
Johnson & Johnson to Quicken Development of Ebola Virus Vaccine
The regimen consists of two vaccine components from Johnson & Johnson's Crucell NV and Denmark-based biotech company Bavarian Nordic, both of which are developing vaccines against filoviruses, including Ebola.
Johnson & Johnson Pushes Ahead With Ebola Vaccine  NPR (blog)
Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate ...  MarketWatch
Related articles »  
Johnson & Johnson Hoping Brand Won't Be Tarnished If They Dip Into Lethal ...
NEW BRUNSWICK, NJ�Saying that the company could cash in big time on the opportunity, Johnson & Johnson CEO Alex Gorsky expressed his hope to reporters Friday that the pharmaceutical manufacturer's family-friendly image would not be tarnished if it ...
Interesting December Stock Options for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call ...
Related articles »  
Johnson & Johnson Should Ignore Those Breakup Calls
Still, there are plenty of investors calling for Johnson & Johnson to break itself up into smaller pieces, even though the company is posting 9% year-over-year revenue growth.
Johnson & Johnson: The One Stock You Should Ever Own? (JNJ)  Seeking Alpha (registration)
Short Interest in Johnson & Johnson Decreases By 13.2% (JNJ)  Mideast Time
Related articles »  
Gas leak evacuates Johnson & Johnson, auto shop on Route 202 in Raritan
"You can smell the gas and we heard the hissing leak, it was really loud," said Jeff Bellew of Classic Auto Body at 1137 Route 202, adjacent to Johnson & Johnson. "We even heard the announcement from J&J's announcement system telling people there to ...
Gilead's Zydelig And Johnson & Johnson-Pharmacyclic's Imbruvica Fighting To ...
Gilead Sciences, Inc. (GILD) and Johnson & Johnson (J&J) (JNJ) seem to be the two major players in the race for developing treatment therapies for leukemia and obtaining approval for their respective drugs in the US and the EU.
Gilead gets EU nod for cancer drug Zydelig  PMLiVE
Related articles »  
Johnson & Johnson gas break fixed; 'back to normal,' police chief says
RARITAN BOROUGH - Repairs have been completed on a gas main break that forced the evacuation Wednesday of about 750 from a Johnson & Johnson building on Route 202. At about 10:30 a.m. Wednesday, a contractor was digging to install a new ...
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher ...
The Dow component that led the way higher today was Johnson & Johnson (NYSE: JNJ), which sported a three-cent gain to $104.58.
Related articles »  
Johnson & Johnson to Seek Buyer for Cordis Medical-Device Unit
The sales process for the business, called Cordis, is at an early stage, the people said. The business, which could fetch between $1.5 billion and $2 billion, is expected to attract interest from private-equity firms and other health-care companies ...
Johnson & Johnson Said Exploring Sale of Cordis Devices Business  Bloomberg
Johnson & Johnson to seek buyer for medical device maker unit: WSJ  Reuters
Related articles »  
J&J Likely To Report Drop In Zytiga Sales On Xtandi's Entry In Prostate Cancer ...
Medivation Inc. (MDVN) and ASTELLAS PHARMA INC.'s (ALPMY) jointly developed drug, Xtandi, is likely to make a dent in the sales of Johnson & Johnson's (JNJ) drug Zytiga given its more favorable safety profile in treating pre-chemotherapy prostate ...